Zovirax Related Published Studies
Well-designed clinical trials related to Zovirax (Acyclovir)
ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo-
and valacyclovir-controlled, dose-finding study. [2012]
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels
during pregnancy and postpartum: a randomized trial. [2012]
Oral acyclovir suppression and neurodevelopment after neonatal herpes. [2011.10.06]
The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women. [2011.10]
Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania. [2011.08]
Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers. [2011.03]
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. [2011.02]
Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. [2011.01]
The effects of daily distress and personality on genital HSV shedding and lesions
in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir
in HSV-2 seropositive women. [2011]
Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial. [2010.11.24]
Use of Acyclovir for Suppression of Human Immunodeficiency Virus Infection Is Not Associated with Genotypic Evidence of Herpes Simplex Virus Type 2 Resistance to Acyclovir: Analysis of Specimens from Three Phase III Trials. [2010.10]
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. [2010.05.01]
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. [2010.04.26]
Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. [2010.04.15]
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. [2010.03.06]
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. [2010.02.04]
Bioequivalence studies of two different film-coated tablet formulations of valacyclovir of two different strengths in healthy volunteers. [2010]
Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers. [2010]
Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients. [2010]
Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy. [2009.12]
A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva. [2009.12]
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. [2009.10.01]
Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. [2009.09]
The course of pain in Bell's palsy: treatment with prednisolone and valacyclovir. [2009.09]
Nonparametric estimator of relative time with application to the Acyclovir Prevention Trial. [2009.08]
Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. [2009.07.15]
Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. [2009.03]
Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus. [2009.02]
Once daily valacyclovir for reducing viral shedding in subjects newly diagnosed with genital herpes. [2009]
A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers. [2008.12]
Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis. [2008.11]
Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. [2008.10.29]
Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. [2008.09.01]
Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial. [2008.09.01]
An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. [2008.07]
The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. [2008.03]
Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study. [2008.02]
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. [2008.01]
Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial. [2008]
Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. [2007.11.15]
Early treatment with prednisolone or acyclovir in Bell's palsy. [2007.10.18]
Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up. [2007.09]
Suppressive Therapy With Valacyclovir in Early Genital Herpes: A Pilot Study of Clinical Efficacy and Herpes-Related Quality of Life. [2007.06]
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. [2007.06]
A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir. [2007.05]
A virologic pilot study of valacyclovir in infectious mononucleosis. [2007.05]
Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. [2007.04]
Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study. [2007.04]
Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. [2007.01]
A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia. [2007.01]
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial. [2006.10]
Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. [2006.09]
Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial. [2006.08.15]
Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. [2006.07]
Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. [2006.07]
Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses. [2006.05]
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. [2006.03.01]
Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. [2006.03]
Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial. [2006]
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo controlled study. [2005.11.10]
A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients. [2005.09]
Valacyclovir to expedite the clearance of recurrent herpes gladiatorum. [2005.09]
A randomized clinical trial of valacyclovir in multiple sclerosis. [2005.06]
Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. [2005.05]
Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection. [2005.02.15]
Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients. [2005]
Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. [2004.11.01]
Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia. [2004.11]
Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. [2004.10.15]
The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. [2004.09]
Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. [2004.07.22]
Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. [2004.04]
No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study. [2004.04]
Once-daily valacyclovir to reduce the risk of transmission of genital herpes. [2004.01.01]
Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study. [2003.12]
Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects. [2003.10.01]
Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. [2003.10]
Role of acyclovir gel in herpes simplex: clinical implications. [2003.07]
Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. [2003.07]
Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. [2003.06]
Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. [2003.04]
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation. [2003.03.15]
Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. [2003.03]
A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. [2003.03]
Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study. [2003.03]
High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. [2003.03]
Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients. [2003.01.27]
A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation. [2002.12]
Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation. [2002.12]
An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. [2002.10.15]
Valacyclovir in the treatment of facial herpes simplex virus infection. [2002.10.15]
Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis. [2002.10]
Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients. [2002.10]
Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. [2002.07]
Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. [2002.06]
Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. [2002.05]
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. [2002.04.15]
Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. [2002.04.01]
Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. [2002.04.01]
Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing. [2002.04]
Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial. [2002.04]
|
